课题基金 / 基金详情

Improving patient outcomes in leukaemia by targeting cancer stem cells

Improving patient outcomes in leukaemia by targeting cancer stem cells
通过靶向癌症干细胞改善白血病患者的预后
批准号：
nhmrc : 1064569
负责人：
A/Pr Steven Lane
金额：
$19.65万
依托单位：
Queensland Institute of Medical Research
依托单位国家：
澳大利亚
项目类别：
Career Development Fellowships
财政年份：
2014
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2014-01-01 至 2018-12-31
来源：
https://researchdata.edu.au/improving-patient-outcomes-stem-cells/455126
关键词：
Improvingpatientoutcomesleukaemiatargeting

项目摘要

项目成果

A/Pr Steven Lane的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Blood cancers such as acute myeloid leukaemia (AML) are among the most deadly types of cancer and new treatments are desperately needed to improve patient’s survival in these diseases. AML cancer-causing stem cells survive by turning on immortalization programs and we hope to specifically kill these AML stem cells by blocking these crucial pathways. This includes things that control the way the cells divide and the way they respond to genetic damage as well as other novel pathways.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The evolution of acute myeloid leukaemia by in situ transformation of haematopoietic stem cells
  • 批准号：
    nhmrc : GNT1098470
  • 项目类别：
    Project Grants
  • 资助金额：
    $64.7万
  • 财政年份：
    2016
  • 负责人：
    A/Pr Steven Lane
  • 依托单位：
The evolution of acute myeloid leukaemia by in situ transformation of haematopoietic stem cells
Targeting leukaemia stem cells through inhibition of telomerase
Targeting leukaemia stem cells through inhibition of telomerase
  • 批准号：
    nhmrc : GNT1098516
  • 项目类别：
    Project Grants
  • 资助金额：
    $65.2万
  • 财政年份：
    2016
  • 负责人：
    A/Pr Steven Lane
  • 依托单位：
海外基金